Arrowpoint Investment Partners »

Travere Therapeutics shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.1M 55k 56.81

More positions owned by Arrowpoint Investment Partners

Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Citigroup Com New (C)
Goldman Sachs (GS)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Global Payments (GPN)
Norfolk Southern (NSC)
American Electric Power Company (AEP)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Ishares Msci Sth Kor Etf Put Option (EWY)
Ishares Msci Taiwan Etf (EWT)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Ishares Tr Expanded Tech Call Option (IGV)
Intel Corporation (INTC)

View all positions for Arrowpoint Investment Partners

Top funds holding Travere Therapeutics

Henderson Group
Jupiter Topco
BlackRock
FMR
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Perceptive Advisors
Nomura Asset Management International
Adage Capital Partners GP
Geode Capital Management
Rock Springs Capital Management
Armistice Capital
Kynam Capital Management
Stephens Investment Management Group

View all funds holding Travere Therapeutics